Trial Profile
Comparison of HbA1c in Type 1 or Type 2 Diabetic Patients Using Insulin Treated Twice Daily With Either Insulin Lispro Low Mixture or Human Insulin Mix 30/70.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2013
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary) ; Insulin suspension isophane/insulin
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms IOPA
- Sponsors Eli Lilly and Company
- 28 Jan 2008 Status change from in progress to completed as reported by clinicaltrials.gov.
- 08 Aug 2007 Status changed from recruiting to in progress.
- 12 Feb 2007 New trial centres added.